// App-Quantinova.ai

: Easix Application in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Prophylaxis

Researchers

Presenter

  • Silvia Escribano Serrat

Principal Investigators

  • Luis Gerardo Rodriguez-Lobato

  • Ana Belén Moreno-Castaño

  • Maria Suarez-Lledo

  • Nuria Martinez-Cibrian

  • María Teresa Solano

  • Jordi Arcarons

  • Meritxell Nomdedeu

  • Joan Cid

  • Miquel Lozano

  • Alexandra Pedraza

  • Laura Rosinol

  • Jordi Esteve

  • Alvaro Urbano-Ispizua

  • Marta Palomo

  • Francesc Fernandez-Aviles

  • Maria Carmen Martinez Munoz

  • Maribel Diaz-Ricart

  • Enric Carreras

  • Montserrat Rovira

  • Maria Queralt Salas

Medical Centers

  • Hematopoietic Transplantation Unit and Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain

  • Hematopathology, Pathology Department, CDB, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain

  • Hematopoietic Transplantation Unit and Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), IDIBAPS, Hospital Clínic de Barcelona, Barcelona, Spain

  • Fundació i Institut de Recerca Josep Carreras contra la leucèmia (Campus Clínic), Barcelona, Spain

  • Department of Hematology and Hemotherapy, Hospital Clínico San Carlos, IdiSSC, Madrid, Spain

  • Apheresis & Cellular Therapy Unit, Department of Hemotherapy and Hemostasis, ICMHO, IDIBAPS, Hospital Clínic, Barcelona, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Creatinine

  • Lactate dehydrogenase

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved